Peyrin-Biroulet, Laurent <br/><br/>
Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.  [electronic resource] 

 -  World journal of gastroenterology  Apr 2007 
 - 2328-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1007-9327 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v13.i16.2328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>C-Reactive Protein--metabolism<br/>Colitis, Ulcerative--blood<br/>Drug Tolerance<br/>Female<br/>Humans<br/>Infliximab<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Remission Induction